Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2023-05-23 Regulatory Filings
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2023
Regulatory Filings Classification · 70% confidence The provided document text appears to be heavily encoded or corrupted, containing no readable or meaningful financial, corporate, or regulatory information. There are no identifiable keywords, regulatory references, report titles, fiscal periods, or any content that would allow classification into a specific filing category. Given the lack of discernible content, the document cannot be classified as a substantive report or announcement. According to the fallback rule, such documents should be classified as Regulatory Filings (RNS). The confidence is moderate due to the inability to extract meaningful information but the fallback category is appropriate.
2023-05-23 English
DFAN14A
Proxy Solicitation & Information Statement
2023-05-23 English
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement
2023-05-22 English
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A proxy statement filed with the SEC, specifically a preliminary proxy statement related to the 2023 Annual Meeting of Stockholders of Masimo Corporation. It includes detailed information about the solicitation of proxies, election of directors, ratification of auditors, and other shareholder voting matters. The document is not an annual report, earnings release, or financial report but rather materials sent to shareholders to provide information and request votes for the annual meeting. This matches the definition of a Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), indicating it is the full proxy statement, not just an announcement or notice. Therefore, the correct classification is PSI with high confidence.
2023-05-22 English
Regulatory Filings 2023
Regulatory Filings Classification · 95% confidence The document is a correspondence letter from Masimo Corporation to the SEC staff responding to comments on a preliminary proxy statement filed on Schedule 14A. It discusses revisions and clarifications to the proxy statement, which is related to shareholder voting and board elections. The document references the filing of a preliminary proxy statement and amendments thereto, and addresses SEC staff comments on disclosures within that proxy statement. This is not the proxy statement itself, nor is it an annual report or earnings release. It is a regulatory correspondence related to a proxy solicitation filing. Therefore, the document is best classified as a Regulatory Filing (RNS), as it does not contain the proxy statement itself but is a letter responding to SEC comments on that filing.
2023-05-19 English
PRER14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934' and is a preliminary proxy statement filed by Masimo Corporation. Proxy statements are materials sent to shareholders to provide information and solicit votes for meetings, typically annual general meetings. The content includes a letter to stockholders from the CEO and independent directors, discussing company performance, strategy, governance, and upcoming annual meeting details. There is no indication that this is an actual annual report, earnings release, or other financial report. The document is a proxy solicitation and information statement as defined in the filing definitions.
2023-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.